International Congress on Cancer Metastasis

cancermetastasis.org

 

8th International Congress on Cancer Metastasis
K

Adjuvant Therapy of Melanoma With Sentinel Node Micrometastasis: Anti-PD-1 Render Superior RFS vs. Ipi, Dabrafenib / Trametinib in Stage 3 V600E/K BRAF Disease Have Survival Advantage

By 8th International Congress on Cancer Metastasis FEATURING Kevin Kim
By 8th International Congress on Cancer Metastasis FEATURING Kevin Kim
142 views
November 28, 2019
Comments 0
Login to view comments. Click here to Login
Current Management of Melanoma Patients
17:42

Spectrum of Micrometastasis in Melanoma Sentinel Lymph Nodes: SN Tum…

8th International Congress on Cancer Metastasis

A. Van Akkooi

27 views
21:53

Should a Completion Lymph Node Dissection Be Done Following a Positi…

8th International Congress on Cancer Metastasis

M. Ross

395 views
19:43

Overview of Neoadjuvant Therapy Options for Regionally Localized or …

8th International Congress on Cancer Metastasis

G. Karakousis

89 views
21:40

Adjuvant Therapy of Melanoma With Sentinel Node Micrometastasis: Ant…

8th International Congress on Cancer Metastasis

K. Kim

142 views